ATE393630T1 - Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten - Google Patents

Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten

Info

Publication number
ATE393630T1
ATE393630T1 AT98920218T AT98920218T ATE393630T1 AT E393630 T1 ATE393630 T1 AT E393630T1 AT 98920218 T AT98920218 T AT 98920218T AT 98920218 T AT98920218 T AT 98920218T AT E393630 T1 ATE393630 T1 AT E393630T1
Authority
AT
Austria
Prior art keywords
amylin
gastritis
agonist
prevention
agonists
Prior art date
Application number
AT98920218T
Other languages
English (en)
Inventor
Andrew Young
Bronislava Gedulin
Gareth Beynon
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE393630T1 publication Critical patent/ATE393630T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98920218T 1997-05-06 1998-05-06 Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten ATE393630T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/851,965 US7101853B2 (en) 1997-05-06 1997-05-06 Method for treating or preventing gastritis using amylin or amylin agonists

Publications (1)

Publication Number Publication Date
ATE393630T1 true ATE393630T1 (de) 2008-05-15

Family

ID=25312164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920218T ATE393630T1 (de) 1997-05-06 1998-05-06 Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten

Country Status (9)

Country Link
US (1) US7101853B2 (de)
EP (2) EP1952819A3 (de)
JP (1) JP2001526656A (de)
AT (1) ATE393630T1 (de)
AU (1) AU7284098A (de)
CA (1) CA2289548A1 (de)
DE (1) DE69839423T2 (de)
ES (1) ES2302353T3 (de)
WO (1) WO1998050059A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739172D1 (de) 1996-08-08 2009-01-29 Amylin Pharmaceuticals Inc Regulation gastrointestinaler beweglichkeit
WO2006083254A1 (en) 2004-02-11 2006-08-10 Amylin Pharmaceuticals, Inc. Amylin family peptides and methods for making and using them
US7399744B2 (en) 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition
WO2006099288A2 (en) * 2005-03-11 2006-09-21 Indevus Pharmaceuticals, Inc. Controlled release formulations of octreotide
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
EP1871403B1 (de) 2005-03-31 2010-09-08 Amylin Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
US11225404B2 (en) 2006-12-13 2022-01-18 Crown Equipment Corporation Information system for industrial vehicles
CA2729139C (en) * 2008-06-25 2016-07-26 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent
EP2303226B1 (de) 2008-06-25 2016-03-23 Endo Pharmaceuticals Solutions Inc. Verlängerte freisetzung von exenatid und anderen polypeptiden
BR102013017626A2 (pt) * 2013-06-14 2015-02-10 Univ Rio De Janeiro Bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, uso de bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, composições farmacêuticas de baixa toxicidade, adjuvante para a prevenção ou tratamento das doenças, medicamento, método de tratamento ou prevenção de doenças.
JP2015066978A (ja) * 2013-09-26 2015-04-13 ヤマハ発動機株式会社 船舶用表示システムおよびそれを備えた小型船舶
PE20180497A1 (es) 2015-03-18 2018-03-09 Zealand Pharma As Analogos de amilina
TWI784968B (zh) 2016-09-09 2022-12-01 丹麥商西蘭製藥公司 澱粉素類似物
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
US11274158B2 (en) * 2018-01-30 2022-03-15 Flagship Pioneering Innovations V, Inc. Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
EP3784265A4 (de) * 2018-04-25 2022-06-22 Janssen Pharmaceutica NV Zyklische thioether-peptid-amylin-rezeptormodulatoren
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514097A (en) 1967-11-13 1970-05-26 Gen Binding Corp Canada Ltd Folding apparatus for paper and the like
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
US4530838A (en) * 1983-07-08 1985-07-23 The Salk Institute For Biological Studies Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
US5367052A (en) 1987-04-27 1994-11-22 Amylin Pharmaceuticals, Inc. Amylin peptides
GB8720115D0 (en) 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
US5175145A (en) 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
US5234906A (en) 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5264372A (en) 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
CA2100745C (en) * 1991-11-19 2007-07-31 Laura S. L. Gaeta Amylin agonist peptides and uses therefor
US5376638A (en) 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
CN1095284A (zh) * 1993-05-15 1994-11-23 浙江永宁制药厂 治疗胃与十二指肠溃疡的药物配方和加工方法
US6114304A (en) 1993-09-07 2000-09-05 Amylin Pharmaceuticals, Inc. Methods for regulating gastrointestinal motility
US6143718A (en) * 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
CN1055219C (zh) * 1995-07-21 2000-08-09 哈尔滨世一堂制药厂 一种治疗胃病的药物及其制法
US5677279A (en) * 1996-12-16 1997-10-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treating pain with amylin or agonists thereof
US6410511B2 (en) 1997-01-08 2002-06-25 Amylin Pharmaceuticals, Inc. Formulations for amylin agonist peptides
US11838193B1 (en) 2022-12-16 2023-12-05 Amazon Technologies, Inc. Real-time load limit measurement for a plurality of nodes

Also Published As

Publication number Publication date
US7101853B2 (en) 2006-09-05
EP0981360B1 (de) 2008-04-30
CA2289548A1 (en) 1998-11-12
AU7284098A (en) 1998-11-27
ES2302353T3 (es) 2008-07-01
EP0981360A1 (de) 2000-03-01
WO1998050059A1 (en) 1998-11-12
US20020010133A1 (en) 2002-01-24
EP0981360A4 (de) 2001-05-23
EP1952819A2 (de) 2008-08-06
JP2001526656A (ja) 2001-12-18
EP1952819A3 (de) 2008-10-22
DE69839423T2 (de) 2009-06-04
DE69839423D1 (de) 2008-06-12

Similar Documents

Publication Publication Date Title
ATE393630T1 (de) Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
ATE322905T1 (de) Verfahren zur hemmung der fibrose mittels eines somatostatin-agonisten
ATE96678T1 (de) Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.
RS49577B (sr) Formulacije analoga insulina
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
NO920051D0 (no) Farmasoeytisk sammensetning for slanking
DE69533112D1 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
ATE185268T1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
PT772451E (pt) Tratamento da diabetes mellitus tipo ii com antagonistas de amilina
ATE125706T1 (de) Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
DE69615984D1 (de) Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen
BR9915390A (pt) Tratamento de tumores através de administração de compostos que liberam harmÈnio de crescimento e seus antagonistas
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
PT980253E (pt) Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
BR9708525A (pt) Método de tratamento de insuficência cardíaca com antagonistas de endotelina
EP0799618A3 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
AR007059A1 (es) Uso de interferon en la preparacion de medicamentos y composiciones via oromucosal o por contacto
PL328924A1 (en) Method of treating abuse of substances
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
YU40198A (sh) Postupak za tretiranje zavisnosti od supstance

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties